摘要
代谢性心血管病主要是指由于代谢危险因素累积造成的心血管疾病,包括高血压、糖尿病、血脂异常、冠心病、卒中等,在我国这类疾病发病率不断上升,且呈年轻化的趋势。不断探索新型生物标志物与检测新方法,规范检验技术,加强临床和检验沟通合作,培养跨学科人才是推进心血管代谢领域检验医学发展的工作重点。
Cardiometabolic disease mainly refers to the cardiovascular disease caused by the increased metabolic burden,including hypertension,diabetes,dyslipidemia,coronary heart disease,stroke,and so on.In China,the incidence of this kind of disease is continuous rising,and cardiometabolic disease is more and more diagnosed in patients in younger age.Currently,continuous exploration of new biomarkers and detection methods,standardization of testing techniques,strengthening of clinical and laboratory communication and cooperation,and cultivation of interdisciplinary talents are the major focuses in term of promoting the development of laboratory medicine in the field of cardiovascular metabolism.
作者
鄢盛恺
潘柏申
Yan Shengkai;Pan Baishen(Department of Laboratory Medicine,Affiliated Hospital of Zunyi Medical University,Zunyi 563003,China;College of Laboratory Medicine,Zunyi Medical University,Zunyi 563006,China;Department of Laboratory Medicine,Zhongshan Hospital Affiliated to Fudan University,Shanghai 200032,China)
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2023年第7期653-655,共3页
Chinese Journal of Laboratory Medicine
基金
国家自然科学基金(82070916)。
关键词
动脉粥样硬化
心血管疾病
营养和代谢性疾病
临床实验室技术
Atherosclerosis
Cardiovascular disease
Nutritional and metabolic diseases
Clinical laboratory technology